The total sale was $10.9 million. For Becton Dickinson, estimates have been trending higher, thanks in part to this earnings surprise history. At this time, Becton Dickinson has an average Growth Score of C, however its Momentum Score is doing a bit better with a B. The firm engages in the development, manufacture and sale of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. Overall, the stock has an aggregate VGM Score of D. Becton Dickinson is a global medical technology company engaged in the development, manufacture, and sale of a broad range of medical supplies, devices, and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The S&P 500 was launched as a index of the United States equities market in 1957. However, the company expects to witness tariff-related headwinds in the current fiscal. ... 2020 Livestream dynaCERT (OTC: DYFSF) (TSX: DYA) Jim Payne explains how DYFSF is … The Price to Book ratio for the last quarter was 2.75, with the Price to … Notable additions include General Motors, Becton Dickinson, Philips Healthcare, SKF, the New Zealand Defense Force, and … Becton Dickinson and Co (BDX) stock has fallen -1.01% while the S&P 500 is higher by 0.36% as of 3:12 PM on Thursday, Oct 1. The live webcast of … Becton, Dickinson and Company BDX, also known as BD, is likely to gain from a series of recent developments and a solid guidance. [ December 12, 2020 ] ‘Halftime Report’ Traders Weigh In On Lockheed Martin, Moderna And Becton Dickinson’s Order For 1 Billion Syringes Trading Ideas [ December 12, 2020 ] Dow Jones Futures: Pfizer Coronavirus Vaccine Distribution Begins; Tesla’s ‘High-Class Problem’; AMD, Shopify Near Buy Points Trading Ideas The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. The company markets its products through independent distribution channels and sales representatives to healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry, and the general public. The cash-plus-stock acquisition is valued at $24 billion. Currently the S&P 500 is only second in popularity to the Dow Jones Industrial Average.You will commonly see performance of a stock portfolio or a certain stock benchmarked against the S&P 500. FRANKLIN LAKES, N.J., Dec. 22, 2020 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will present at the 39 th Annual J.P. Morgan Healthcare Conference via webcast. Becton, Dickinson & Co. is a medical technology company. Becton, Dickinson and Company BDX, also known as BD, is likely to gain from a series of recent developments and a solid guidance. Let's see if Becton, Dickinson (BDX) stock is a good choice for value-oriented investors right now from multiple angles. Becton Dickinson follows other major Healthcare sector earnings this month. Becton Dickinson said the tests will be distributed this month. Macy's (M) – The retailer's stock is being removed from the S&P 500 index and will be placed in the S&P SmallCap 600 as of April 6. Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. However, expected annual FFO-per-share growth of ~5.9%, plus the 4.7% dividend yield lead to expected total annual returns of 10.4% per year over the next five years. Chairman, CEO and President of Becton, Dickinson And Co (30-Year Financial, Insider Trades) Vincent A Forlenza (insider trades) sold 39,007 shares of BDX on 01/27/2020 at an average price of $280.09 a share. The S&P 500 contains five hundred of the US market's leading public companies. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. Becton, Dickinson and Company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey. In a year’s time, shares of BD have gained 27.2% compared with the industry’s 9% rise. Notwithstanding this, Becton stock reacted negatively 61% of the time, with an average decline of 0.5%, the research firm said. The Average True Range (ATR) for Becton Dickinson and Company is set at 6.90, with the Price to Sales ratio for BDX stock in the period of the last 12 months amounting to 4.03. From the COVID-19 panic to the Dutch Tulip mania in 1637, here are 10 of the worst stock market crashes in history. Intraday chart for BECTON, DICKINSON AND COMPANY Daily chart BECTON, DICKINSON AND COMPANY Duration : Auto. Becton Dickinson and Co (BDX) stock is down -2.57% while the S&P 500 is up 1.02% as of 11:46 AM on Thursday, Aug 27. However, the stock was allocated a grade of D on the value side, putting it in the bottom 40% for this investment strategy. Becton, Dickinson and Co. reported U$2.88 billion in Cash and Equivalent for its second fiscal quarter of 2020. And when you look at the stock's positive Zacks Earnings ESP (Expected Surprise Prediction), it's a great indicator of a future earnings beat, especially when combined with … 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max. The Standard and Poor's S&P 500. Becton, Dickinson and Company is set to report its second-quarter fiscal 2014 earnings results on May 1, 2014. [ September 2, 2020 ] Billionaire investor Mario Gabelli explains ‘problem’ with Tesla stock Trading Ideas [ September 2, 2020 ... U.S. regulator greenlights Becton Dickinson's rapid antigen test for COVID-19. Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. Becton Dickinson and Co will invest about $1.2 billion to boost syringe production, the world's largest needle maker said on Wednesday, as the United States inches closer to … BD's CEO and president is scheduled to present on Tuesday, January 12, 2021 at 7:30 a.m. Eastern Time.. Becton, Dickinson & Co., $78.35, symbol BDX on New York (Shares outstanding: 223.6 million; Market cap: $17.5 billion; www.bd.com), has three main businesses. Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Becton Dickinson's report follows an earnings beat by J&J on Tuesday, April 14, 2020, who reported EPS of $2.3 on revenue of $20.69B, compared to forecasts EPS of $2.02 on revenue of $19.73B. BDX has fallen -$2.34 from the previous closing price of $232.71 on volume of 826,972 shares. Dividend Aristocrat #6: Becton, Dickinson, & Co. (BDX) Becton, Dickinson and Company () Stock Market info Recommendations: Buy or sell Becton, Dickinson and stock? BDX: Get the latest Becton, Dickinson & stock price and detailed information including BDX news, historical charts and realtime prices. Becton, Dickinson and Company is a medical technology company engaged principally in the development, manufacture and sale of a range of medical supplies, devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. In the last reported quarter, the company had posted a 10.08% positive surprise. We view Federal Realty stock as overvalued, and a declining valuation multiple will reduce shareholder returns. BDX is lower by -$6.53 from the previous closing price of $253.98 on volume of 2,013,357 shares. Becton, Dickinson And Co (BDX) Chairman, CEO and President Vincent A Forlenza Sold $10.9 million of Shares. Becton, Dickinson and Co. stock price, live market quote, shares value, historical data, intraday chart, earnings per share and news. Per management, Becton, Dickinson is on its way to become one of the biggest medical technology devices company in the world with this buyout.